Skip to content

Porcine Acellular Dermal Matrix for the Treatment of Localized Gingival Recessions

Porcine Acellular Dermal Matrix for the Treatment of Localized Gingival Recessions: A Multicenter Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06006780
Enrollment
40
Registered
2023-08-23
Start date
2022-09-10
Completion date
2024-12-30
Last updated
2025-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingival Recession

Brief summary

Aim: The aim of this randomized clinical trial is to evaluate the use of the porcine acellular dermal matrix (PADM) for the treatment of RT1 localized gingival recessions. Material and methods: Forthy patients (n=20) with RT1 localized gingival recessions with height ranging from 3 to 5 mm with and at least, 2mm of keratinized tissue width will be selected to participate in the study. Patients will be allocated randomly in two treatment groups: Coronally advanced flap (CAF) or coronally advanced flap associated with the porcine acellular dermal matrix (CAF+ PADM). The clinical parameters evaluated at the baseline, 6 and 12 months will be: Plaque index (IPL); gingival index (GI); relative gingival recession height (RGRH); gingival recession width (GRW); probing depth (PD); relative clinical attachment level (RCAL); keratinized tissue height (KTH); keratinized tissue thickness (KTT); papilla height (PH). Evaluations will be made by the professional and the patient regarding dentin hypersensitivity (HD) (Schiff and VAS scales respectively), aesthetics (RES and VAS scales, respectively) and patient's centered outcomes, through the questionnaire referring to the OHIP-14. Descriptive statistical analysis will be expressed as mean ± standard deviation (SD), median, quartiles, percentages and confidence intervals (95% CI). To analyze the normality of the residue, the Shapiro-Wilk test will be performed. Then, the Wilcoxon test will be applied to compare the periodontal parameters and a quality of life, before and post-treatment. Correlations between parameters and dental hypersensitivity will be analyzed through Spearman's test. Key words: Gingival recession, Root coverage, Biomaterial, Acellular dermal matrix.

Interventions

DEVICEPorcine acellular dermal matrix

Coronally advanced flap associated with the porcine acellular dermal matrix for root coverage

Coronally advanced flap for root coverage

Sponsors

University of Campinas, Brazil
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* RT1 localized gingival recessions with height ranging from 3 to 5 mm; * 2mm or more of keratinized tissue width ; * Probing depth less than 3mm; * Plaque and gingival index less or equal to 20%.

Exclusion criteria

* Smokers; * Pregnants; * Nursing; * Patients with diabetes mellitus or another condition that interfere in the tissue repair * Patients who use drugs or medications that interfere in the tissue repair; * Allergies to any composition of the devices of the study.

Design outcomes

Primary

MeasureTime frameDescription
Recession changeBaseline, 6 months and 12 monthsChange of the gingival recession height

Secondary

MeasureTime frameDescription
Thickness of keratinized tissueBaseline, 6 months and 12 monthsThickness of keratinized tissue evaluation after periodontal plastic surgery

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026